Open Access
Vet. Res.
Volume 38, Number 3, May-June 2007
Page(s) 419 - 433
Published online 13 March 2007
How to cite this article Vet. Res. (2007) 419-433
References of  Vet. Res. 38 (2007) 419-433
  1. Baigent S.J., Davison F., Marek's disease virus: biology and life cycle, in: Davison F., Nair V.K. (Eds.), Marek's disease. An evolving problem, Elsevier Academic Press, Compton, UK, 2004, Biology of animal infections, pp. 62-77.
  2. Besser J., Sommer M.H., Zerboni L., Bagowski C.P., Ito H., Moffat J., Ku C.C., Arvin A.M., Differentiation of varicella-zoster virus ORF47 protein kinase and IE62 protein binding domains and their contributions to replication in human skin xenografts in the SCID-hu mouse, J. Virol. (2003) 77:5964-5974 [CrossRef] [PubMed].
  3. Besser J., Ikoma M., Fabel K., Sommer M.H., Zerboni L., Grose C., Arvin A.M., Differential requirement for cell fusion and virion formation in the pathogenesis of varicella-zoster virus infection in skin and T cells, J. Virol. (2004) 78:13293-13305 [CrossRef] [PubMed].
  4. Calnek B.W., Adldinger H.K., Kahn D.E., Feather follicle epithelium: a source of enveloped and infectious cell- free herpesvirus from Marek's disease, Avian Dis. (1970) 14:219-233 [CrossRef] [PubMed].
  5. Coulter L.J., Moss H.W., Lang J., McGeoch D.J., A mutant of herpes simplex virus type 1 in which the UL13 protein kinase gene is disrupted, J. Gen. Virol. (1993) 74:387-395 [PubMed].
  6. Cunningham C., Davison A.J., Dolan A., Frame M.C., McGeoch D.J., Meredith D.M., Moss H.W., Orr A.C., The UL13 virion protein of herpes simplex virus type 1 is phosphorylated by a novel virus-induced protein kinase, J. Gen. Virol. (1992) 73:303-311 [PubMed].
  7. Dorange F., El Mehdaoui S., Pichon C., Coursaget P., Vautherot J.F., Marek's disease virus (MDV) homologues of herpes simplex virus type 1 UL49 (VP22) and UL48 (VP16) genes: high-level expression and characterization of MDV-1 VP22 and VP16, J. Gen. Virol. (2000) 81:2219-2230 [PubMed].
  8. Dorange F., Tischer B.K., Vautherot J.F., Osterrieder N., Characterization of Marek's disease virus serotype 1 (MDV-1) deletion mutants that lack UL46 to UL49 genes: MDV-1 UL49, encoding VP22, is indispensable for virus growth, J. Virol. (2002) 76:1959-1970 [CrossRef] [PubMed].
  9. Heineman T.C., Cohen J.I., The varicella-zoster virus (VZV) open reading frame 47 (ORF47) protein kinase is dispensable for viral replication and is not required for phosphorylation of ORF63 protein, the VZV homolog of herpes simplex virus ICP22, J. Virol. (1995) 69:7367-7370 [PubMed].
  10. Jarosinski K.W., Osterrieder N., Nair V.K., Schat K.A., Attenuation of Marek's disease virus by deletion of open reading frame RLORF4 but not RLORF5a, J. Virol. (2005) 79:11647-11659 [CrossRef] [PubMed].
  11. Kamil J.P., Tischer B.K., Trapp S., Nair V.K., Osterrieder N., Kung H.J., vLIP, a viral lipase homologue, is a virulence factor of Marek's disease virus, J. Virol. (2005) 79:6984-6996 [CrossRef] [PubMed].
  12. Kato A., Yamamoto M., Ohno T., Tanaka M., Sata T., Nishiyama Y., Kawaguchi Y., Herpes simplex virus 1-encoded protein kinase UL13 phosphorylates viral Us3 protein kinase and regulates nuclear localization of viral envelopment factors UL34 and UL31, J. Virol. (2006) 31:1476-1486 [CrossRef].
  13. Kawaguchi Y., Van Sant C., Roizman B., Eukaryotic elongation factor 1delta is hyperphosphorylated by the protein kinase encoded by the U(L)13 gene of herpes simplex virus 1, J. Virol. (1998) 72:1731-1736 [PubMed].
  14. Kingston E., Introduction of DNA into mammalian cells, in: Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Seidman J.G., Smith J.A., Struhl K. (Eds.), Current Protocols in Molecular Biology, John Wiley and Sons, Inc., Boston, USA, 2001, Current Protocols, Vol. 1, pp. 9.0.1-9.1.11.
  15. Klopfleisch R., Klupp B.G., Fuchs W., Kopp M., Teifke J.P., Mettenleiter T.C., Influence of pseudorabies virus proteins on neuroinvasion and neurovirulence in mice, J. Virol. (2006) 80:5571-5576 [CrossRef] [PubMed].
  16. Ku C.C., Besser J., Abendroth A., Grose C., Arvin A.M., Varicella-Zoster virus pathogenesis and immunobiology: new concepts emerging from investigations with the SCIDhu mouse model, J. Virol. (2005) 79:2651-2658 [CrossRef] [PubMed].
  17. Lee L.F., Wu P., Sui D., Ren D., Kamil J., Kung H.J., Witter R.L., The complete unique long sequence and the overall genomic organization of the GA strain of Marek's disease virus, Proc. Natl. Acad. Sci. USA (2000) 97:6091-6096 [CrossRef] [PubMed].
  18. Moffat J.F., Zerboni L., Sommer M.H., Heineman T.C., Cohen J.I., Kaneshima H., Arvin A.M., The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse, Proc. Natl. Acad. Sci. USA (1998) 95:11969-11974 [CrossRef] [PubMed].
  19. Ng T.I., Ogle W.O., Roizman B., UL13 protein kinase of herpes simplex virus 1 complexes with glycoprotein E and mediates the phosphorylation of the viral Fc receptor: glycoproteins E and I, Virology (1998) 241:37-48 [CrossRef] [PubMed].
  20. Ogle W.O., Ng T.I., Carter K.L., Roizman B., The UL13 protein kinase and the infected cell type are determinants of posttranslational modification of ICP0, Virology (1997) 235:406-413 [CrossRef] [PubMed].
  21. Petherbridge L., Brown A.C., Baigent S.J., Howes K., Sacco M.A., Osterrieder N., Nair V.K., Oncogenicity of virulent Marek's disease virus cloned as bacterial artificial chromosomes, J. Virol. (2004) 78:13376-13380 [CrossRef] [PubMed].
  22. Purves F.C., Roizman B., The UL13 gene of herpes simplex virus 1 encodes the functions for posttranslational processing associated with phosphorylation of the regulatory protein alpha 22, Proc. Natl. Acad. Sci. USA (1992) 89:7310-7314 [CrossRef] [PubMed].
  23. Reddy S.M., Cox E., Iofin I., Soong W., Cohen J.I., Varicella-zoster virus (VZV) ORF32 encodes a phosphoprotein that is posttranslationally modified by the VZV ORF47 protein kinase, J. Virol. (1998) 72:8083-8088 [PubMed].
  24. Reddy S.M., Sui D., Wu P., Lee L., Identification and structural analysis of a MDV gene encoding a protein kinase, Acta Virol. (1999) 43:174-180 [PubMed].
  25. Ronfort C., Afanassieff M., Chebloune Y., Dambrine G., Nigon V.M., Verdier G., Identification and structure analysis of endogenous proviral sequences in a Brown Leghorn chicken strain, Poult. Sci. (1991) 70:2161-2175 [PubMed].
  26. Schumacher D., Tischer B.K., Fuchs W., Osterrieder N., Reconstitution of Marek's disease virus serotype 1 (MDV-1) from DNA cloned as a bacterial artificial chromosome and characterization of a glycoprotein B-negative MDV-1 mutant, J. Virol. (2000) 74:11088-11098 [CrossRef] [PubMed].
  27. Sinzger C., Knapp J., Schmidt K., Kahl M., Jahn G., A simple and rapid method for preparation of viral DNA from cell associated cytomegalovirus, J. Virol. Methods (1999) 81:115-122 [CrossRef] [PubMed].
  28. Soong W., Schultz J.C., Patera A.C., Sommer M.H., Cohen J.I., Infection of human T lymphocytes with varicella-zoster virus: an analysis with viral mutants and clinical isolates, J. Virol. (2000) 74:1864-1870 [CrossRef] [PubMed].
  29. Spengler M., Niesen N., Grose C., Ruyechan W.T., Hay J., Interactions among structural proteins of varicella zoster virus, Arch. Virol. Suppl. (2001) 71-79.
  30. Tanaka M., Nishiyama Y., Sata T., Kawaguchi Y., The role of protein kinase activity expressed by the UL13 gene of herpes simplex virus 1: the activity is not essential for optimal expression of UL41 and ICP0, Virology (2005) 341:301-312 [CrossRef] [PubMed].
  31. Tischer B.K., von Einem J., Kaufer B., Osterrieder N., Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli, Biotechniques (2006) 40:191-197 [PubMed].
  32. Tulman E.R., Afonso C.L., Lu Z., Zsak L., Rock D.L., Kutish G.F., The genome of a very virulent Marek's disease virus, J. Virol. (2000) 74:7980-7988 [CrossRef] [PubMed].